Craft

Cantel Medical

Revenue

$1 B

FY, 2020

Cantel Medical Summary

Company Summary

Overview
Cantel Medical is a company that provides infection prevention products and services for the healthcare market. The company operates through four segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. The Endoscopy segment offers automated endoscope reprocessing systems, detergents, leak testing and manual cleaning products, storage cabinets, transport systems, and mobile medical carts. The Water Purification and Filtration segment provides water purification systems, bicarbonate systems, liquid disinfectants, and cold sterilization products. The Healthcare Disposables segment offers biological and chemical integrators, sterilization pouches, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, shields, and hand sanitizers. The Dialysis segment provides medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates, and other supplies for renal dialysis.
Type
Subsidiary
Status
Active
Founded
1963
HQ
Little Falls, NJ, US | view all locations
Website
https://www.cantelmedical.eu/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Neil Blewitt
  • Michael Drexel

    Michael Drexel, Senior Vice President, Chief Technology Officer

Operating MetricsView all

Backlog

72.4M
8.3%

FY, 2016

Patents (US)

55

FY, 2016

Patents (Foreign)

167

FY, 2016

LocationsView all

14 locations detected

  • Little Falls, NJ HQ

    United States

    150 Clove Rd

  • Heatherton, VIC

    Australia

    9 Arco Ln

  • Richmond Hill, ON

    Canada

    6 East Beaver Creek Rd

  • Shanghai, Shanghai

    China

    Unit 804-805, Innov Tower Block A, 1801 Hongmei Road, Xuhui

  • Toulouse

    France

    3 Rue Du Pre Ferme

  • Düsseldorf, Nordrhein-Westfalen

    Germany

    35 Heerdter Lohweg

and 8 others

Cantel Medical Financials

Summary Financials

Revenue (Q3, 2021)
$314.0M
Gross profit (Q3, 2021)
$151.3M
Net income (Q3, 2021)
$21.1M
Cash (Q3, 2021)
$218.5M
EBIT (Q3, 2021)
$45.5M

Footer menu